After Achieving 100% Cancer Remission Rates In Preclinical Studies, Starpax Magnetodrones Head For Human Trials

Starpax Biopharma is preparing to start clinical trials this year with its patented Starpax cancer treatment platform across six unmet needs, including pancreatic, breast, colorectal, head & neck, uterus and prostate cancer.

Related Keywords

Canada ,London ,City Of ,United Kingdom ,Jacques Jolivet ,Starpax Magnetodrones ,John Helou ,Starpax Biopharma ,Lisa Matar ,Berthe Latreille ,Micheal Gareau ,King Georges ,Jp Morgan Investment Bank ,Drug Administration ,Johnson France ,Eli Lilly ,King Georgesv Silver Jubilee Medal ,Investment Bank ,